Skip to main content
OpenTrials

Clinical trial condition

Hepatic Insufficiency

Explore clinical trials studying Hepatic Insufficiency. Study availability and eligibility vary by location and protocol.

73 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hepatic Insufficiency trial results

Completed

A Single Dose Study of LY2605541 in Participants With Liver Impairment

NCT01751399

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munich, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Balatonfüred, Hungary
View Trial Details
Completed

A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

NCT01836185

Conditions
Digestive System Diseases, Hepatic Insufficiency, Liver Diseases
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
View Trial Details
Completed

A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease

NCT01870388

Conditions
Digestive System Diseases, Hepatic Insufficiency, Liver Diseases
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
View Trial Details

Related conditions